Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres
By M. Pressoir, S. Desné, D. Berchery, G. Rossignol, B. Poirée, M. Meslier, S. Traversier, M. Vittot, M. Simon, J. Gekiere and 10 more. British Journal of Cancer, 2010
606 citations recorded by the source corpus.
Background:This epidemiological observational study aimed at determining the prevalence of malnutrition in non-selected adults with cancer, to identify risk factors of malnutrition and correlate the results with length of stay and 2-month mortality.Methods:This prospective multicentre 1-day study conducted in 17 French Comprehensive Cancer Centres included 1545 patients. Body mass index (BMI), weight loss (WL) in the past 6 months and age were routinely recorded according to the French national recommendations for hospitalised patients; malnutrition was rated as absent, moderate or severe according to the level of WL and BMI. Age, sex, tumour site, type of hospitalisation and treatment, disease stage, World Health Organisation performance status (PS) and antibiotic therapy were the potential malnutrition risk factors tested. Follow-up at 2 months allowed to determine the correlation with length of stay and mortality.Results:Malnutrition was reported in 30.9% of patients, and was rated as severe in 12.2%. In multivariate analysis, only pre-existing obesity (BMI⩾30), PS ⩾2 and head-and-neck or upper digestive cancers were associated with increased risk of malnutrition. Antibiotics use was significantly higher in malnourished patients (35.5 vs 22.8%; P<0.001). Severe malnutrition was independently associated with mortality. The median length of stay was 19.3±19.4 days for malnourished patients vs 13.3±19.4 days for others (P<0.0001).Conclusion:In French Comprehensive Cancer Centres, one out of three cancer patients are malnourished and this was associated with a longer length of stay. Pre-existing obesity could be identified as a new risk factor for malnutrition in our cancer patient population perhaps because of a misidentification or a delay in nutrition support in this category of patients.
Subfields: Geriatrics and Gerontology, Oncology, Physiology
View Paper: https://www.semanticscholar.org/paper/bc765c1ae4bb9c5836bf1690b68aab64a2cb07ab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Physiology
Citations in the corpus
- ESPEN guidelines on nutrition in cancer patients. (2017, background): “Cancer patients are at risk of malnutrition, not only due to physical and metabolic effects of the cancer, but also due to the effects of anticancer therapies, and malnutrition is associated with poorer prognosis [2,3].”
- ESPEN expert group recommendations for action against cancer-related malnutrition. (2017, background): “In terms of outcomes that affect healthcare costs, length of stay in hospital was longer in malnourished patients with cancer [1,5,21], and overall costs were increased by as much as V2000 per hospitalization”
- Prevalence of malnutrition and current use of nutrition support in patients with cancer. (2014, background): “9%.(19) However, in that study, the percentage of patients with breast cancer was high (25% of patients vs 12% in this study), and the prevalence of malnutrition is known to be lower in these patients.”